Literature DB >> 27681385

De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease.

Lijiang Ma1, Yavuz Bayram2, Heather M McLaughlin3, Megan T Cho3, Alyson Krokosky4, Clesson E Turner4, Kristin Lindstrom5, Caleb P Bupp6, Katey Mayberry6, Weiyi Mu7, Joann Bodurtha7, Veronique Weinstein8, Neda Zadeh9, Wendy Alcaraz10, Zöe Powis10, Yunru Shao2, Daryl A Scott2,11, Andrea M Lewis2, Janson J White2, Shalani N Jhangiani2,12, Elif Yilmaz Gulec13, Seema R Lalani2, James R Lupski2,12,14,15, Kyle Retterer3, Rhonda E Schnur3, Ingrid M Wentzensen3, Sherri Bale3, Wendy K Chung16.   

Abstract

Intellectual disabilities are genetically heterogeneous and can be associated with congenital anomalies. Using whole-exome sequencing (WES), we identified five different de novo missense variants in the protein phosphatase-1 catalytic subunit beta (PPP1CB) gene in eight unrelated individuals who share an overlapping phenotype of dysmorphic features, macrocephaly, developmental delay or intellectual disability (ID), congenital heart disease, short stature, and skeletal and connective tissue abnormalities. Protein phosphatase-1 (PP1) is a serine/threonine-specific protein phosphatase involved in the dephosphorylation of a variety of proteins. The PPP1CB gene encodes a PP1 subunit that regulates the level of protein phosphorylation. All five altered amino acids we observed are highly conserved among the PP1 subunit family, and all are predicted to disrupt PP1 subunit binding and impair dephosphorylation. Our data suggest that our heterozygous de novo PPP1CB pathogenic variants are associated with syndromic intellectual disability.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27681385      PMCID: PMC5663278          DOI: 10.1007/s00439-016-1731-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  42 in total

Review 1.  Structural basis for protein phosphatase 1 regulation and specificity.

Authors:  Wolfgang Peti; Angus C Nairn; Rebecca Page
Journal:  FEBS J       Date:  2012-02-24       Impact factor: 5.542

Review 2.  The phosphoprotein phosphatase family of Ser/Thr phosphatases as principal targets of naturally occurring toxins.

Authors:  Susana R Pereira; Vítor M Vasconcelos; Agostinho Antunes
Journal:  Crit Rev Toxicol       Date:  2011-02       Impact factor: 5.635

3.  Whole-genome sequencing for optimized patient management.

Authors:  Matthew N Bainbridge; Wojciech Wiszniewski; David R Murdock; Jennifer Friedman; Claudia Gonzaga-Jauregui; Irene Newsham; Jeffrey G Reid; John K Fink; Margaret B Morgan; Marie-Claude Gingras; Donna M Muzny; Linh D Hoang; Shahed Yousaf; James R Lupski; Richard A Gibbs
Journal:  Sci Transl Med       Date:  2011-06-15       Impact factor: 17.956

4.  Reciprocally interacting domains of protein phosphatase 1 and focal adhesion kinase.

Authors:  Mariarita Bianchi; Stefania De Lucchini; Michele Vietri; Emma Villa-Moruzzi
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

5.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies.

Authors:  Jason Homsy; Samir Zaidi; Yufeng Shen; James S Ware; Kaitlin E Samocha; Konrad J Karczewski; Steven R DePalma; David McKean; Hiroko Wakimoto; Josh Gorham; Sheng Chih Jin; John Deanfield; Alessandro Giardini; George A Porter; Richard Kim; Kaya Bilguvar; Francesc López-Giráldez; Irina Tikhonova; Shrikant Mane; Angela Romano-Adesman; Hongjian Qi; Badri Vardarajan; Lijiang Ma; Mark Daly; Amy E Roberts; Mark W Russell; Seema Mital; Jane W Newburger; J William Gaynor; Roger E Breitbart; Ivan Iossifov; Michael Ronemus; Stephan J Sanders; Jonathan R Kaltman; Jonathan G Seidman; Martina Brueckner; Bruce D Gelb; Elizabeth Goldmuntz; Richard P Lifton; Christine E Seidman; Wendy K Chung
Journal:  Science       Date:  2015-12-04       Impact factor: 47.728

6.  Protein Phosphatase 1 Beta is Modulated by Chronic Hypoxia and Involved in the Angiogenic Endothelial Cell Migration.

Authors:  Dominga Iacobazzi; Indira Garaeva; Ambra Albertario; Myriam Cherif; Gianni D Angelini; Massimo Caputo; Mohamed T Ghorbel
Journal:  Cell Physiol Biochem       Date:  2015-05-07

7.  Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1.

Authors:  J T Maynes; K S Bateman; M M Cherney; A K Das; H A Luu; C F Holmes; M N James
Journal:  J Biol Chem       Date:  2001-09-04       Impact factor: 5.157

8.  The major myosin phosphatase in skeletal muscle is a complex between the beta-isoform of protein phosphatase 1 and the MYPT2 gene product.

Authors:  G Moorhead; D Johnson; N Morrice; P Cohen
Journal:  FEBS Lett       Date:  1998-11-06       Impact factor: 4.124

9.  A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.

Authors:  Karen W Gripp; Kimberly A Aldinger; James T Bennett; Laura Baker; Jessica Tusi; Nina Powell-Hamilton; Deborah Stabley; Katia Sol-Church; Andrew E Timms; William B Dobyns
Journal:  Am J Med Genet A       Date:  2016-06-05       Impact factor: 2.802

10.  Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes.

Authors:  Xin He; Stephan J Sanders; Li Liu; Silvia De Rubeis; Elaine T Lim; James S Sutcliffe; Gerard D Schellenberg; Richard A Gibbs; Mark J Daly; Joseph D Buxbaum; Matthew W State; Bernie Devlin; Kathryn Roeder
Journal:  PLoS Genet       Date:  2013-08-15       Impact factor: 5.917

View more
  13 in total

Review 1.  cAMP regulation of protein phosphatases PP1 and PP2A in brain.

Authors:  Shannon N Leslie; Angus C Nairn
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-09-18       Impact factor: 4.739

2.  Quantitative cardiac phosphoproteomics profiling during ischemia-reperfusion in an immature swine model.

Authors:  Dolena Ledee; Min A Kang; Masaki Kajimoto; Samuel Purvine; Heather Brewer; Ljiljana Pasa-Tolic; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-04-28       Impact factor: 4.733

3.  Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.

Authors:  Jason J Kwon; Behnoush Hajian; Yuemin Bian; Lucy C Young; Alvaro J Amor; James R Fuller; Cara V Fraley; Abbey M Sykes; Jonathan So; Joshua Pan; Laura Baker; Sun Joo Lee; Douglas B Wheeler; David L Mayhew; Nicole S Persky; Xiaoping Yang; David E Root; Anthony M Barsotti; Andrew W Stamford; Charles K Perry; Alex Burgin; Frank McCormick; Christopher T Lemke; William C Hahn; Andrew J Aguirre
Journal:  Nature       Date:  2022-07-13       Impact factor: 69.504

4.  SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.

Authors:  Lucy C Young; Nicole Hartig; Isabel Boned Del Río; Sibel Sari; Benjamin Ringham-Terry; Joshua R Wainwright; Greg G Jones; Frank McCormick; Pablo Rodriguez-Viciana
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

5.  The sixth international RASopathies symposium: Precision medicine-From promise to practice.

Authors:  Karen W Gripp; Lisa Schill; Lisa Schoyer; Beth Stronach; Anton M Bennett; Susan Blaser; Amanda Brown; Rebecca Burdine; Emma Burkitt-Wright; Pau Castel; Sandra Darilek; Alwyn Dias; Tuesdi Dyer; Michelle Ellis; Gregg Erickson; Bruce D Gelb; Tamar Green; Andrea Gross; Alan Ho; James Lloyd Holder; Shin-Ichi Inoue; Angie C Jelin; Annie Kennedy; Richard Klein; Maria I Kontaridis; Pilar Magoulas; Darryl B McConnell; Frank McCormick; Benjamin G Neel; Carlos E Prada; Katherine A Rauen; Amy Roberts; Pablo Rodriguez-Viciana; Neal Rosen; Gavin Rumbaugh; Anna Sablina; Maja Solman; Marco Tartaglia; Angelica Thomas; William C Timmer; Kartik Venkatachalam; Karin S Walsh; Pamela L Wolters; Jae-Sung Yi; Martin Zenker; Nancy Ratner
Journal:  Am J Med Genet A       Date:  2019-12-11       Impact factor: 2.802

6.  Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.

Authors:  Ikumi Umeki; Tetsuya Niihori; Taiki Abe; Shin-Ichiro Kanno; Nobuhiko Okamoto; Seiji Mizuno; Kenji Kurosawa; Keisuke Nagasaki; Makoto Yoshida; Hirofumi Ohashi; Shin-Ichi Inoue; Yoichi Matsubara; Ikuma Fujiwara; Shigeo Kure; Yoko Aoki
Journal:  Hum Genet       Date:  2018-10-27       Impact factor: 4.132

7.  Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders.

Authors:  Hoang T Nguyen; Julien Bryois; April Kim; Amanda Dobbyn; Laura M Huckins; Ana B Munoz-Manchado; Douglas M Ruderfer; Giulio Genovese; Menachem Fromer; Xinyi Xu; Dalila Pinto; Sten Linnarsson; Matthijs Verhage; August B Smit; Jens Hjerling-Leffler; Joseph D Buxbaum; Christina Hultman; Pamela Sklar; Shaun M Purcell; Kasper Lage; Xin He; Patrick F Sullivan; Eli A Stahl
Journal:  Genome Med       Date:  2017-12-20       Impact factor: 11.117

8.  Epileptic spasms in PPP1CB-associated Noonan-like syndrome: a case report with clinical and therapeutic implications.

Authors:  Chien-Heng Lin; Wei-De Lin; I-Ching Chou; Inn-Chi Lee; Hueng-Chuen Fan; Syuan-Yu Hong
Journal:  BMC Neurol       Date:  2018-09-20       Impact factor: 2.474

9.  Differential localizations of protein phosphatase 1 isoforms determine their physiological function in the heart.

Authors:  Ruijie Liu; Christian Miller; Christiana D'Annibale; Kimberly Vo; Ashley Jacobs
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2019-03-01       Impact factor: 3.848

10.  Prioritized High-Confidence Risk Genes for Intellectual Disability Reveal Molecular Convergence During Brain Development.

Authors:  Zhenwei Liu; Na Zhang; Yu Zhang; Yaoqiang Du; Tao Zhang; Zhongshan Li; Jinyu Wu; Xiaobing Wang
Journal:  Front Genet       Date:  2018-09-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.